Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 44, Issue 8 968-983, Copyright © 1995 by American Diabetes Association

ARTICLES

The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial


The Diabetes Control and Complications Trial (DCCT) demonstrated that a regimen of intensive therapy aimed at maintaining near-normal blood glucose values markedly reduces the risks of development or progression of retinopathy and other complications of insulin-dependent diabetes mellitus (IDDM) when compared with a conventional treatment regimen. This report presents an epidemiological assessment of the association between levels of glycemic exposure (HbA1c) before and during the DCCT with the risk of retinopathy progression within each treatment group. The initial level of HbA1c observed at eligibility screening as an index of pre-DCCT glycemia and the duration of IDDM on entry were the dominant baseline predictors of the risk of progression. The shorter the duration of IDDM on entry, the greater were the benefits of intensive therapy. In each treatment group, the mean HbA1c during the trial was the dominant predictor of retinopathy progression, and the risk gradients were similar in the two groups; a 10% lower HbA1c (e.g., 8 vs. 7.2%) is associated with a 43% lower risk in the intensive group and a 45% lower risk in the conventional group. These risk gradients applied over the observed range of HbA1c values and were unaffected by adjustment for other covariates. Over the range of HbA1c achieved by DCCT intensive therapy, there does not appear to be a level of glycemia below which the risks of retinopathy progression are eliminated. The change in risk over time, however, differed significantly between the treatment groups, the risk increasing with time in the study in the conventional group but remaining relatively constant in the intensive group. The risks were compounded by a multiplicative effect of the level of HbA1c with the duration of exposure (time in study). Total glycemic exposure was the dominant factor associated with the risk of retinopathy progression. When examined simultaneously within each treatment group, each of the components of pre-DCCT glycemic exposure (screening HbA1c value and IDDM duration) and glycemic exposure during the DCCT (mean HbA1c, time in study, and their interaction) were significantly associated with risk of retinopathy progression. Similar results also apply to other retinopathic, nephropathic, and neuropathic outcomes. The recommendation of the DCCT remains that intensive therapy with the goal of achieving near-normal glycemia should be implemented as early as possible in as many IDDM patients as is safely possible.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Arch OphthalmolHome page
F. A. Sloan, D. Belsky, D. Ruiz Jr, and P. Lee
Changes in Incidence of Diabetes Mellitus-Related Eye Disease Among US Elderly Persons, 1994-2005
Arch Ophthalmol, November 1, 2008; 126(11): 1548 - 1553.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
A. Ceriello, K. Esposito, L. Piconi, M. A. Ihnat, J. E. Thorpe, R. Testa, M. Boemi, and D. Giugliano
Oscillating Glucose Is More Deleterious to Endothelial Function and Oxidative Stress Than Mean Glucose in Normal and Type 2 Diabetic Patients
Diabetes, May 1, 2008; 57(5): 1349 - 1354.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
J. M. Lachin, S. Genuth, D. M. Nathan, B. Zinman, B. N. Rutledge, and for the DCCT/EDIC Research Group
Effect of Glycemic Exposure on the Risk of Microvascular Complications in the Diabetes Control and Complications Trial--Revisited
Diabetes, April 1, 2008; 57(4): 995 - 1001.
[Abstract] [Full Text] [PDF]

Home page
 Am J Health Syst PharmHome page
Z. T. Bloomgarden
Screening for and managing diabetic retinopathy: Current approaches
Am. J. Health Syst. Pharm., September 1, 2007; 64(17_Supplement_12): S8 - S14.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
Q. Mohamed, M. C. Gillies, and T. Y. Wong
Management of Diabetic Retinopathy: A Systematic Review
JAMA, August 22, 2007; 298(8): 902 - 916.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
J. M. Lachin, S. Genuth, D. M. Nathan, and B. N. Rutledge
The Hemoglobin Glycation Index Is Not an Independent Predictor of the Risk of Microvascular Complications in the Diabetes Control and Complications Trial
Diabetes, July 1, 2007; 56(7): 1913 - 1921.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
E. S. Kilpatrick, A. S. Rigby, and S. L. Atkin
Variability in the Relationship between Mean Plasma Glucose and HbA1c: Implications for the Assessment of Glycemic Control
Clin. Chem., May 1, 2007; 53(5): 897 - 901.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
M. B. Davidson
Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A Consensus Statement From the American Diabetes Association and the European Association for the Study of Diabetes: Response to Jellinger, Lebovitz, and Davidson
Diabetes Care, April 1, 2007; 30(4): e18 - e20.
[Full Text] [PDF]

Home page
 Diabetes CareHome page
M. B. Davidson
Clinical Implications of the DREAM Study
Diabetes Care, February 1, 2007; 30(2): 418 - 420.
[Full Text] [PDF]

Home page
 Diabetes CareHome page
T. J. Orchard, T. Costacou, R. G. Miller, C. T. Prince, and G. Pambianco
Modeling Chronic Glycemic Exposure Variables as Correlates and Predictors of Microvascular Complications of Diabetes: Response to Dyck et al.
Diabetes Care, February 1, 2007; 30(2): 448 - 448.
[Full Text] [PDF]

Home page
 Diabetes CareHome page
I. B. Hirsch and M. Brownlee
The Effect of Glucose Variability on the Risk of Microvascular Complications in Type 1 Diabetes: Response to Kilpatrick et al. and Bolli
Diabetes Care, January 1, 2007; 30(1): 186 - 187.
[Full Text] [PDF]

Home page
 Diabetes CareHome page
J.-H. Cho, S.-A. Chang, H.-S. Kwon, Y.-H. Choi, S.-H. Ko, S.-D. Moon, S.-J. Yoo, K.-H. Song, H.-S. Son, H.-S. Kim, et al.
Long-Term Effect of the Internet-Based Glucose Monitoring System on HbA1c Reduction and Glucose Stability: A 30-month follow-up study for diabetes management with a ubiquitous medical care system
Diabetes Care, December 1, 2006; 29(12): 2625 - 2631.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
D. Deiss, J. Bolinder, J.-P. Riveline, T. Battelino, E. Bosi, N. Tubiana-Rufi, D. Kerr, and M. Phillip
Improved Glycemic Control in Poorly Controlled Patients with Type 1 Diabetes Using Real-Time Continuous Glucose Monitoring
Diabetes Care, December 1, 2006; 29(12): 2730 - 2732.
[Full Text] [PDF]

Home page
 DiabetesHome page
P. A. Cleary, T. J. Orchard, S. Genuth, N. D. Wong, R. Detrano, J.-Y. C. Backlund, B. Zinman, A. Jacobson, W. Sun, J. M. Lachin, et al.
The Effect of Intensive Glycemic Treatment on Coronary Artery Calcification in Type 1 Diabetic Participants of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study
Diabetes, December 1, 2006; 55(12): 3556 - 3565.
[Abstract] [Full Text] [PDF]

Home page
 The Diabetes EducatorHome page
J. M. Boltri, M. Davis-Smith, L. E. Zayas, S. Shellenberger, J. P. Seale, T. W. Blalock, and A. Mbadinuju
Developing a Church-Based Diabetes Prevention Program With African Americans: Focus Group Findings
The Diabetes Educator, November 1, 2006; 32(6): 901 - 909.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
B. P. Kovatchev, E. Otto, D. Cox, L. Gonder-Frederick, and W. Clarke
Evaluation of a new measure of blood glucose variability in diabetes.
Diabetes Care, November 1, 2006; 29(11): 2433 - 2438.
[Abstract] [Full Text] [PDF]

Home page
 BiostatisticsHome page
Y. H. Sparling, N. Younes, J. M. Lachin, and O. M. Bautista
Parametric survival models for interval-censored data with time-dependent covariates
Biostat., October 1, 2006; 7(4): 599 - 614.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
D. A. Antonetti, A. J. Barber, S. K. Bronson, W. M. Freeman, T. W. Gardner, L. S. Jefferson, M. Kester, S. R. Kimball, J. K. Krady, K. F. LaNoue, et al.
Diabetic Retinopathy: Seeing Beyond Glucose-Induced Microvascular Disease
Diabetes, September 1, 2006; 55(9): 2401 - 2411.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
D. M. Nathan, J. B. Buse, M. B. Davidson, R. J. Heine, R. R. Holman, R. Sherwin, and B. Zinman
Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes
Diabetes Care, August 1, 2006; 29(8): 1963 - 1972.
[Full Text] [PDF]

Home page
 Am J EpidemiolHome page
T. LeCaire, M. Palta, H. Zhang, C. Allen, R. Klein, and D. D'Alessio
Lower-than-Expected Prevalence and Severity of Retinopathy in an Incident Cohort followed during the First 4-14 Years of Type 1 Diabetes: The Wisconsin Diabetes Registry Study
Am. J. Epidemiol., July 15, 2006; 164(2): 143 - 150.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
E. S. Kilpatrick, A. S. Rigby, and S. L. Atkin
The Effect of Glucose Variability on the Risk of Microvascular Complications in Type 1 Diabetes
Diabetes Care, July 1, 2006; 29(7): 1486 - 1490.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
G. B. Bolli
Glucose Variability and Complications
Diabetes Care, July 1, 2006; 29(7): 1707 - 1709.
[Full Text] [PDF]

Home page
 Diabetes CareHome page
M. T. Tran, M. D. Navar, and M. B. Davidson
Comparison of the Glycemic Effects of Rosiglitazone and Pioglitazone in Triple Oral Therapy in Type 2 Diabetes.
Diabetes Care, June 1, 2006; 29(6): 1395 - 1396.
[Full Text] [PDF]

Home page
 J. Am. Podiatr. Med. Assoc.Home page
J. La Fontaine, L. B. Harkless, C. E. Davis, M. A. Allen, and P. K. Shireman
Current concepts in diabetic microvascular dysfunction.
J Am Podiatr Med Assoc, May 1, 2006; 96(3): 245 - 252.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
L. Monnier, E. Mas, C. Ginet, F. Michel, L. Villon, J.-P. Cristol, and C. Colette
Activation of Oxidative Stress by Acute Glucose Fluctuations Compared With Sustained Chronic Hyperglycemia in Patients With Type 2 Diabetes
JAMA, April 12, 2006; 295(14): 1681 - 1687.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
C. D. Saudek, R. L. Derr, and R. R. Kalyani
Assessing Glycemia in Diabetes Using Self-monitoring Blood Glucose and Hemoglobin A1c
JAMA, April 12, 2006; 295(14): 1688 - 1697.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
M. Brownlee and I. B. Hirsch
Glycemic Variability: A Hemoglobin A1c-Independent Risk Factor for Diabetic Complications
JAMA, April 12, 2006; 295(14): 1707 - 1708.
[Full Text] [PDF]

Home page
 Diabetes CareHome page
R. J. McCarter, J. M. Hempe, and S. A. Chalew
Mean Blood Glucose and Biological Variation Have Greater Influence on HbA1c Levels Than Glucose Instability: An analysis of data from the Diabetes Control and Complications Trial
Diabetes Care, February 1, 2006; 29(2): 352 - 355.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
S. Garg, H. Zisser, S. Schwartz, T. Bailey, R. Kaplan, S. Ellis, and L. Jovanovic
Improvement in Glycemic Excursions With a Transcutaneous, Real-Time Continuous Glucose Sensor: A randomized controlled trial
Diabetes Care, January 1, 2006; 29(1): 44 - 50.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
M. R. Carnethon, M. Gulati, and P. Greenland
Prevalence and Cardiovascular Disease Correlates of Low Cardiorespiratory Fitness in Adolescents and Adults
JAMA, December 21, 2005; 294(23): 2981 - 2988.
[Abstract] [Full Text] [PDF]

Home page
 DOC NewsHome page
N. G. Clark
Defending ADA's A1C Target
DOC News, October 1, 2005; 2(10): 3 - 3.
[Full Text]

Home page
 Diabetes CareHome page
F. Mohsin, M. E Craig, J. Cusumano, A. K.F. Chan, S. Hing, J. W. Lee, M. Silink, N. J. Howard, and K. C. Donaghue
Discordant Trends in Microvascular Complications in Adolescents With Type 1 Diabetes From 1990 to 2002
Diabetes Care, August 1, 2005; 28(8): 1974 - 1980.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
M. Steffes, P. Cleary, D. Goldstein, R. Little, H.-M. Wiedmeyer, C. Rohlfing, J. England, J. Bucksa, M. Nowicki, and the DCCT/EDIC Research Group
Hemoglobin A1c Measurements over Nearly Two Decades: Sustaining Comparable Values throughout the Diabetes Control and Complications Trial and the Epidemiology of Diabetes Interventions and Complications Study
Clin. Chem., April 1, 2005; 51(4): 753 - 758.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
A. Ceriello
Postprandial Hyperglycemia and Diabetes Complications: Is It Time to Treat?
Diabetes, January 1, 2005; 54(1): 1 - 7.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
M. B. Davidson
Early Insulin Therapy for Type 2 Diabetic Patients: More Cost Than Benefit
Diabetes Care, January 1, 2005; 28(1): 222 - 224.
[Full Text] [PDF]

Home page
 Diabetes CareHome page
S. Genuth, J. M. Lachin, and D. M. Nathan
Biological Variation in HbA1c Predicts Risk of Retinopathy and Nephropathy in Type 1 Diabetes: Response to McCarter et al.
Diabetes Care, January 1, 2005; 28(1): 233 - 233.
[Full Text] [PDF]

Home page
 DiabetesHome page
J. R. Nyengaard, Y. Ido, C. Kilo, and J. R. Williamson
Interactions Between Hyperglycemia and Hypoxia: Implications for Diabetic Retinopathy
Diabetes, November 1, 2004; 53(11): 2931 - 2938.
[Abstract] [Full Text] [PDF]

Home page
 Arch OphthalmolHome page
UK Prospective Diabetes Study (UKPDS) Group
Risks of Progression of Retinopathy and Vision Loss Related to Tight Blood Pressure Control in Type 2 Diabetes Mellitus: UKPDS 69
Arch Ophthalmol, November 1, 2004; 122(11): 1631 - 1640.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
N. F. Sheard, N. G. Clark, J. C. Brand-Miller, M. J. Franz, F. X. Pi-Sunyer, E. Mayer-Davis, K. Kulkarni, and P. Geil
Dietary Carbohydrate (Amount and Type) in the Prevention and Management of Diabetes: A statement by the American Diabetes Association
Diabetes Care, September 1, 2004; 27(9): 2266 - 2271.
[Full Text] [PDF]

Home page
 Diabetes CareHome page
R. Roy, M. Navar, G. Palomeno, and M. B. Davidson
Real World Effectiveness of Rosiglitazone Added to Maximal (Tolerated) Doses of Metformin and a Sulfonylurea Agent: A systematic evaluation of triple oral therapy in a minority population
Diabetes Care, July 1, 2004; 27(7): 1741 - 1742.
[Full Text] [PDF]

Home page
 Diabetes CareHome page
R. J. McCarter, J. M. Hempe, R. Gomez, and S. A. Chalew
Biological Variation in HbA1c Predicts Risk of Retinopathy and Nephropathy in Type 1 Diabetes
Diabetes Care, June 1, 2004; 27(6): 1259 - 1264.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
P. E. Cryer
Diverse Causes of Hypoglycemia-Associated Autonomic Failure in Diabetes
N. Engl. J. Med., May 27, 2004; 350(22): 2272 - 2279.
[Full Text] [PDF]

Home page
 American Journal of Medical QualityHome page
V. N. Joish, D. C. Malone, C. Wendel, and M. J. Mohler
Profiling Quality of Diabetes Care in a Veterans Mfairs Healthcare System
American Journal of Medical Quality, May 1, 2004; 19(3): 112 - 120.
[Abstract] [PDF]

Home page
 IOVSHome page
T. J. Lyons, A. J. Jenkins, D. Zheng, D. T. Lackland, D. McGee, W. T. Garvey, and R. L. Klein
Diabetic Retinopathy and Serum Lipoprotein Subclasses in the DCCT/EDIC Cohort
Invest. Ophthalmol. Vis. Sci., March 1, 2004; 45(3): 910 - 918.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
H. A. Hancock and T. W. Kraft
Oscillatory Potential Analysis and ERGs of Normal and Diabetic Rats
Invest. Ophthalmol. Vis. Sci., March 1, 2004; 45(3): 1002 - 1008.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
S. K. Garg, S. Schwartz, and S. V. Edelman
Improved Glucose Excursions Using an Implantable Real-Time Continuous Glucose Sensor in Adults With Type 1 Diabetes
Diabetes Care, March 1, 2004; 27(3): 734 - 738.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
D. L. Schriger and B. Lorber
Lowering the Cut Point for Impaired Fasting Glucose: Where is the evidence? Where is the logic?
Diabetes Care, February 1, 2004; 27(2): 592 - 595.
[Full Text] [PDF]

Home page
 The Diabetes EducatorHome page
J. K. Dickinson and M. M. O'Reilly
The Lived Experience of Adolescent Females With Type 1 Diabetes
The Diabetes Educator, January 1, 2004; 30(1): 99 - 107.
[PDF]

Home page
 Diabetes CareHome page
Z. T. Bloomgarden
Aspects of Blood Pressure, Lipid, and Glycemic Treatment
Diabetes Care, January 1, 2004; 27(1): 264 - 269.
[Full Text] [PDF]

Home page
 JAMAHome page
Writing Team for the Diabetes Control and Complica
Sustained Effect of Intensive Treatment of Type 1 Diabetes Mellitus on Development and Progression of Diabetic Nephropathy: The Epidemiology of Diabetes Interventions and Complications (EDIC) Study
JAMA, October 22, 2003; 290(16): 2159 - 2167.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
R. Derr, E. Garrett, G. A. Stacy, and C. D. Saudek
Is HbA1c Affected by Glycemic Instability?
Diabetes Care, October 1, 2003; 26(10): 2728 - 2733.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
B. M. Svoren, D. Butler, B.-S. Levine, B. J. Anderson, and L. M. B. Laffel
Reducing Acute Adverse Outcomes in Youths With Type 1 Diabetes: A Randomized, Controlled Trial
Pediatrics, October 1, 2003; 112(4): 914 - 922.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
J. B. Brown, K. L. Pedula, and K. H. Summers
Diabetic Retinopathy: Contemporary prevalence in a well-controlled population
Diabetes Care, September 1, 2003; 26(9): 2637 - 2642.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Z. Y. Jiang, Z. He, B. L. King, T. Kuroki, D. M. Opland, K. Suzuma, I. Suzuma, K. Ueki, R. N. Kulkarni, C. R. Kahn, et al.
Characterization of Multiple Signaling Pathways of Insulin in the Regulation of Vascular Endothelial Growth Factor Expression in Vascular Cells and Angiogenesis
J. Biol. Chem., August 22, 2003; 278(34): 31964 - 31971.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
M. B. Davidson
The Case for "Outsourcing" Diabetes Care
Diabetes Care, May 1, 2003; 26(5): 1608 - 1612.
[Full Text] [PDF]

Home page
 Diabetes CareHome page
J. B. Buse
Should Postprandial Glucose Be Routinely Measured and Treated to a Particular Target? No!
Diabetes Care, May 1, 2003; 26(5): 1615 - 1618.
[Full Text] [PDF]

Home page
 Diabetes CareHome page
H. P. Chase
Glycemic Control in Prepubertal Years
Diabetes Care, April 1, 2003; 26(4): 1304 - 1305.
[Full Text] [PDF]

Home page
 Diabetes CareHome page
C. Levetan, L. L. Want, C. Weyer, S. A. Strobel, J. Crean, Y. Wang, D. G. Maggs, O. G. Kolterman, M. Chandran, S. R. Mudaliar, et al.
Impact of Pramlintide on Glucose Fluctuations and Postprandial Glucose, Glucagon, and Triglyceride Excursions Among Patients With Type 1 Diabetes Intensively Treated With Insulin Pumps
Diabetes Care, January 1, 2003; 26(1): 1 - 8.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
Implications of the Diabetes Control and Complications Trial
Diabetes Care, Janua